<?xml version='1.0' encoding='utf-8'?>
<document id="24636064"><sentence text="Inhibitory effect of medicinal plant-derived carboxylic acids on the human transporters hOAT1, hOAT3, hOATP1B1, and hOATP2B1."><entity charOffset="45-61" id="DDI-PubMed.24636064.s1.e0" text="carboxylic acids" /></sentence><sentence text="A significant number of organic carboxylic acids have been shown to influence the absorption and distribution of drugs mediated by organic anion transporters (OATs)"><entity charOffset="32-48" id="DDI-PubMed.24636064.s2.e0" text="carboxylic acids" /></sentence><sentence text=" In this study, uptake experiments were performed to assess the inhibitory effects of cinnamic acid, ferulic acid, oleanolic acid, deoxycholic acid, and cynarin on hOAT1, hOAT3, hOATP1B1, and hOATP2B1"><entity charOffset="86-99" id="DDI-PubMed.24636064.s3.e0" text="cinnamic acid" /><entity charOffset="101-113" id="DDI-PubMed.24636064.s3.e1" text="ferulic acid" /><entity charOffset="115-129" id="DDI-PubMed.24636064.s3.e2" text="oleanolic acid" /><entity charOffset="131-147" id="DDI-PubMed.24636064.s3.e3" text="deoxycholic acid" /><entity charOffset="153-160" id="DDI-PubMed.24636064.s3.e4" text="cynarin" /><entity charOffset="171-176" id="DDI-PubMed.24636064.s3.e5" text="hOAT3" /><entity charOffset="178-186" id="DDI-PubMed.24636064.s3.e6" text="hOATP1B1" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e0" e2="DDI-PubMed.24636064.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e0" e2="DDI-PubMed.24636064.s3.e1" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e0" e2="DDI-PubMed.24636064.s3.e2" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e0" e2="DDI-PubMed.24636064.s3.e3" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e0" e2="DDI-PubMed.24636064.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e0" e2="DDI-PubMed.24636064.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e0" e2="DDI-PubMed.24636064.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e1" e2="DDI-PubMed.24636064.s3.e1" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e1" e2="DDI-PubMed.24636064.s3.e2" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e1" e2="DDI-PubMed.24636064.s3.e3" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e1" e2="DDI-PubMed.24636064.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e1" e2="DDI-PubMed.24636064.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e1" e2="DDI-PubMed.24636064.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e2" e2="DDI-PubMed.24636064.s3.e2" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e2" e2="DDI-PubMed.24636064.s3.e3" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e2" e2="DDI-PubMed.24636064.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e2" e2="DDI-PubMed.24636064.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e2" e2="DDI-PubMed.24636064.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e3" e2="DDI-PubMed.24636064.s3.e3" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e3" e2="DDI-PubMed.24636064.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e3" e2="DDI-PubMed.24636064.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e3" e2="DDI-PubMed.24636064.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e4" e2="DDI-PubMed.24636064.s3.e4" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e4" e2="DDI-PubMed.24636064.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e4" e2="DDI-PubMed.24636064.s3.e6" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e5" e2="DDI-PubMed.24636064.s3.e5" /><pair ddi="false" e1="DDI-PubMed.24636064.s3.e5" e2="DDI-PubMed.24636064.s3.e6" /></sentence><sentence text=" After a drug-drug interaction (DDI) investigation, cinnamic acid, ferulic acid, deoxycholic acid, and cynarin were found and validated to inhibit hOAT1 in a competitive manner, and deoxycholic acid was found to be an inhibitor of all four transporters"><entity charOffset="52-65" id="DDI-PubMed.24636064.s4.e0" text="cinnamic acid" /><entity charOffset="67-79" id="DDI-PubMed.24636064.s4.e1" text="ferulic acid" /><entity charOffset="81-97" id="DDI-PubMed.24636064.s4.e2" text="deoxycholic acid" /><entity charOffset="182-198" id="DDI-PubMed.24636064.s4.e3" text="deoxycholic acid" /><pair ddi="false" e1="DDI-PubMed.24636064.s4.e0" e2="DDI-PubMed.24636064.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24636064.s4.e0" e2="DDI-PubMed.24636064.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24636064.s4.e0" e2="DDI-PubMed.24636064.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24636064.s4.e0" e2="DDI-PubMed.24636064.s4.e3" /><pair ddi="false" e1="DDI-PubMed.24636064.s4.e1" e2="DDI-PubMed.24636064.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24636064.s4.e1" e2="DDI-PubMed.24636064.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24636064.s4.e1" e2="DDI-PubMed.24636064.s4.e3" /><pair ddi="false" e1="DDI-PubMed.24636064.s4.e2" e2="DDI-PubMed.24636064.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24636064.s4.e2" e2="DDI-PubMed.24636064.s4.e3" /></sentence><sentence text=" The apparent 50% inhibitory concentrations of cinnamic acid, ferulic acid, deoxycholic acid, and cynarin were estimated to be 133"><entity charOffset="47-60" id="DDI-PubMed.24636064.s5.e0" text="cinnamic acid" /><entity charOffset="62-74" id="DDI-PubMed.24636064.s5.e1" text="ferulic acid" /><entity charOffset="76-92" id="DDI-PubMed.24636064.s5.e2" text="deoxycholic acid" /><pair ddi="false" e1="DDI-PubMed.24636064.s5.e0" e2="DDI-PubMed.24636064.s5.e0" /><pair ddi="false" e1="DDI-PubMed.24636064.s5.e0" e2="DDI-PubMed.24636064.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24636064.s5.e0" e2="DDI-PubMed.24636064.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24636064.s5.e1" e2="DDI-PubMed.24636064.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24636064.s5.e1" e2="DDI-PubMed.24636064.s5.e2" /></sentence><sentence text="87, 3" /><sentence text="69, 90" /><sentence text="03 and 6" /><sentence text="03 μmol·L(-1) for hOAT1, respectively" /><sentence text=" The apparent 50% inhibitory concentrations of deoxycholic acid were estimated to be 9"><entity charOffset="47-63" id="DDI-PubMed.24636064.s10.e0" text="deoxycholic acid" /></sentence><sentence text="57 μmol·L(-1) for hOAT3, 70"><entity charOffset="18-33" id="DDI-PubMed.24636064.s11.e0" text="hOAT3" /></sentence><sentence text="54 μmol·L(-1) for hOATP1B1, and 168" /><sentence text="27 μmol·L(-1) for hOATP2B1" /><sentence text=" Because cinnamic acid, ferulic acid, and cynarin are ingredients of food or food additives, the present study suggests there are new food-drug interactions to be disclosed"><entity charOffset="9-22" id="DDI-PubMed.24636064.s14.e0" text="cinnamic acid" /><entity charOffset="24-36" id="DDI-PubMed.24636064.s14.e1" text="ferulic acid" /><pair ddi="false" e1="DDI-PubMed.24636064.s14.e0" e2="DDI-PubMed.24636064.s14.e0" /><pair ddi="false" e1="DDI-PubMed.24636064.s14.e0" e2="DDI-PubMed.24636064.s14.e1" /></sentence><sentence text=" In addition, deoxycholic acid may be used as a probe for studying the correlation of OATs and OATPs"><entity charOffset="14-30" id="DDI-PubMed.24636064.s15.e0" text="deoxycholic acid" /></sentence><sentence text=" " /></document>